WallStreetZenWallStreetZen

NASDAQ: NMTC
Neuroone Medical Technologies Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for NMTC

Based on 2 analysts offering 12 month price targets for Neuroone Medical Technologies Corp

Min Forecast
$1.45+84.71%
Avg Forecast
$2.23+183.44%
Max Forecast
$3.00+282.17%

Should I buy or sell NMTC stock?

Based on 2 analysts offering ratings for Neuroone Medical Technologies Corp.

Strong Buy
Strong Buy
2 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although NMTC's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates NMTC as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their NMTC stock forecasts and price targets.

NMTC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-09-09
lockedlocked$00.00+00.00%2025-05-05

1 of 1

Forecast return on equity

Is NMTC forecast to generate an efficient return?

Company
N/A
Industry
24.78%
Market
146.17%

Forecast return on assets

Is NMTC forecast to generate an efficient return on assets?

Company
N/A
Industry
13.18%

NMTC earnings per share forecast

What is NMTC's earnings per share in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.15
Avg 2 year Forecast
-$0.12

NMTC revenue forecast

What is NMTC's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$11.5M+19.24%
Avg 2 year Forecast
$15.1M+56.43%
Avg 3 year Forecast
$23.5M+143.96%
NMTC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NMTC revenue growth forecast

How is NMTC forecast to perform vs Medical Devices companies and vs the US market?

Company
32.64%
Industry
8.03%
Market
25.27%
NMTC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NMTC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NMTC vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
NMTC$0.79$2.23+183.44%Strong Buy
ELUT$0.90$6.00+564.45%Strong Buy
ECOR$5.04N/AN/A
MYO$0.97$7.83+711.71%Buy
ICCM$0.75$2.50+234.67%Buy
View Top Medical Device Stocks

Neuroone Medical Technologies Stock Forecast FAQ

Is Neuroone Medical Technologies Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: NMTC) stock is to Strong Buy NMTC stock.

Out of 2 analysts, 2 (100%) are recommending NMTC as a Strong Buy, 0 (0%) are recommending NMTC as a Buy, 0 (0%) are recommending NMTC as a Hold, 0 (0%) are recommending NMTC as a Sell, and 0 (0%) are recommending NMTC as a Strong Sell.

If you're new to stock investing, here's how to buy Neuroone Medical Technologies stock.

What is NMTC's earnings growth forecast for 2026-2027?

(NASDAQ: NMTC) Neuroone Medical Technologies's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 14.14%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 40.98%.

Neuroone Medical Technologies's earnings in 2025 is -$5,336,748.On average, 4 Wall Street analysts forecast NMTC's earnings for 2026 to be -$7,394,929, with the lowest NMTC earnings forecast at -$7,349,929, and the highest NMTC earnings forecast at -$7,349,929.

In 2027, NMTC is forecast to generate -$5,864,944 in earnings, with the lowest earnings forecast at -$5,879,943 and the highest earnings forecast at -$5,774,944.

What is NMTC's revenue growth forecast for 2026-2028?

(NASDAQ: NMTC) Neuroone Medical Technologies's forecast annual revenue growth rate of 32.64% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.03%, and it is also forecast to beat the US market's average forecast revenue growth rate of 25.27%.

Neuroone Medical Technologies's revenue in 2025 is $9,629,051.On average, 4 Wall Street analysts forecast NMTC's revenue for 2026 to be $574,094,477, with the lowest NMTC revenue forecast at $495,545,233, and the highest NMTC revenue forecast at $650,993,737. On average, 4 Wall Street analysts forecast NMTC's revenue for 2027 to be $753,142,755, with the lowest NMTC revenue forecast at $594,644,279, and the highest NMTC revenue forecast at $913,491,212.

In 2028, NMTC is forecast to generate $1,174,538,701 in revenue, with the lowest revenue forecast at $1,128,439,144 and the highest revenue forecast at $1,209,088,368.

What is NMTC's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: NMTC) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 13.18%.

What is NMTC's Price Target?

According to 2 Wall Street analysts that have issued a 1 year NMTC price target, the average NMTC price target is $2.23, with the highest NMTC stock price forecast at $3.00 and the lowest NMTC stock price forecast at $1.45.

On average, Wall Street analysts predict that Neuroone Medical Technologies's share price could reach $2.23 by Sep 9, 2026. The average Neuroone Medical Technologies stock price prediction forecasts a potential upside of 183.44% from the current NMTC share price of $0.79.

What is NMTC's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: NMTC) Neuroone Medical Technologies's current Earnings Per Share (EPS) is -$0.15. On average, analysts forecast that NMTC's EPS will be -$0.15 for 2026, with the lowest EPS forecast at -$0.15, and the highest EPS forecast at -$0.15. In 2027, NMTC's EPS is forecast to hit -$0.12 (min: -$0.12, max: -$0.12).

What is NMTC's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: NMTC) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.